@article{6c040b4e6dc34df881076dd971952416,
title = "Prostate cancer, version 1.2016: Featured updates to the NCCN guidelines",
abstract = "The NCCN Guidelines for Prostate Cancer address staging and risk assessment after an initial diagnosis of prostate cancer and management options for localized, regional, and metastatic disease. Recommendations for disease monitoring, treatment of recurrent disease, and systemic therapy for metastatic castration-recurrent prostate cancer also are included. This article summarizes the NCCN Prostate Cancer Panel's most significant discussions for the 2016 update of the guidelines, which include refinement of risk stratification methods and new options for the treatment of men with high-risk and very-high-risk disease and progressive castration-na{\"i}ve disease.",
author = "Mohler, {James L.} and Armstrong, {Andrew J.} and Bahnson, {Robert R.} and D'Amico, {Anthony Victor} and Davis, {Brian J.} and Eastham, {James A.} and Enke, {Charles A.} and Farrington, {Thomas A.} and Higano, {Celestia S.} and Horwitz, {Eric M.} and Michael Hurwitz and Kane, {Christopher J.} and Kawachi, {Mark H.} and Michael Kuettel and Lee, {Richard J.} and Meeks, {Joshua J.} and Penson, {David F.} and Plimack, {Elizabeth R.} and Pow-Sang, {Julio M.} and David Raben and Sylvia Richey and Mack Roach and Stan Rosenfeld and Edward Schaeffer and Skolarus, {Ted A.} and Small, {Eric J.} and Guru Sonpavde and Sandy Srinivas and Strope, {Seth A.} and Jonathan Tward and Shead, {Dorothy A.} and Freedman-Cass, {Deborah A.}",
note = "Publisher Copyright: {\textcopyright} 2016 JNCCN-Journal of the National Comprehensive Cancer Network.",
year = "2016",
month = jan,
day = "1",
doi = "10.6004/jnccn.2016.0004",
language = "English (US)",
volume = "14",
pages = "19--30",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "1",
}